Cookies disclaimer

I agree Our site saves small pieces of text information (cookies) on your device in order to deliver better content and for statistical purposes. You can disable the usage of cookies by changing the settings of your browser. By browsing our website without changing the browser settings you grant us permission to store that information on your device.



Mabion S.A. is a biotechnology company focusing on research, development, and manufacturing activities aimed at developing and commercially introducing biotech drugs based on the monoclonal antibody technology amongst others, to the market. The main objective of the Company's activity is development, manufacture and marketing of drugs biosimilar to the marketed original biotechnological drugs (so-called reference products) in the area of oncology, autoimmunity, neurology and metabolic diseases.

Also, the Company has potential and resources to conduct research, development, and manufacturing tasks in the field of vaccine and innovative therapies in response to the current SARS-CoV-2 pandemic.


© Mabion S.A. all rights reserved Polityka Prywatności